Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martina Mahelová is active.

Publication


Featured researches published by Martina Mahelová.


International Journal of Molecular Sciences | 2014

Candida parapsilosis Biofilm Identification by Raman Spectroscopy

Ota Samek; Katarína Mlynáriková; Silvie Bernatová; Jan Ježek; Vladislav Krzyžánek; Martin Šiler; Pavel Zemánek; Filip Růžička; Veronika Holá; Martina Mahelová

Colonies of Candida parapsilosis on culture plates were probed directly in situ using Raman spectroscopy for rapid identification of specific strains separated by a given time intervals (up to months apart). To classify the Raman spectra, data analysis was performed using the approach of principal component analysis (PCA). The analysis of the data sets generated during the scans of individual colonies reveals that despite the inhomogeneity of the biological samples unambiguous associations to individual strains (two biofilm-positive and two biofilm-negative) could be made.


Journal of Microbiology Immunology and Infection | 2015

Phenotypes of Escherichia coli isolated from urine: Differences between extended-spectrum β-lactamase producers and sensitive strains

Petra Šišková; Lenka Černohorská; Martina Mahelová; Kristýna Turková; Vladana Woznicová

BACKGROUND Escherichia coli is a frequent causative agent of urinary tract infections, and increasing resistance of E. coli to antimicrobials presents a growing challenge. METHODS Here we compare phenotypes of extended-spectrum β-lactamase (ESBL) producers (n = 220) with a control group of sensitive strains (non-ESBL producers; n = 150). For each strain, we assessed the presence of O25 antigen, hemolysis, biofilm production, sensitivity to antibiotics, and biochemical profile. RESULTS Compared to the control group, ESBL producers were more frequently O25 positive (6.0% vs. 42.3%) and less frequently hemolytic (34.7% vs. 6.4%). Comparison of biofilm production in brain-heart infusion (BHI) and in BHI with 4% glucose supplementation showed that ESBL-positive strains produced biofilm in BHI with glucose less intensely than the control group (p < 0.05). Most ESBL producers were ciprofloxacin-resistant (91.8%). Biochemical analyses revealed that ESBL producers more frequently utilized inositol, ornithine, sorbitol, melibiose, and saccharose, whereas the control group more frequently used esculin, lysine, arginine, and dulcitol. The control group strains with O25 antigen were more commonly resistant to ciprofloxacin (p < 0.05). Pulsed-field gel electrophoresis results showed higher variability among the control group of sensitive strains. CONCLUSION These findings suggest a potential to detect ESBL strains based on virulence factors and biochemical properties, which could be useful in shaping proper empiric antimicrobial therapy, and for initiating such therapy as soon as possible.


Folia Microbiologica | 2016

Evaluation of capacity to detect ability to form biofilm in Candida parapsilosis sensu stricto strains by MALDI-TOF MS

Katarína Mlynáriková; Ondrej Šedo; Filip Růžička; Zbyněk Zdráhal; Veronika Holá; Martina Mahelová

Matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) is, currently, used as a rapid and reliable tool in microbial diagnostics. The discriminatory power of the method extends its applicability also beyond species level. This study examined the possibility to use MALDI-TOF MS to differentiate between Candida parapsilosis sensu stricto biofilm-positive (n = 12) and biofilm-negative (n = 9) strains. The results indicated a grouping trend within MALDI-TOF mass spectra belonging to each of the tested groups. However, these trends were eclipsed by mass spectral variations resulting from limited repeatability of the method, making its application for the selected purpose impossible. Improvement in the discriminatory power of the method was not obtained neither by using different matrices (α-cyano-4-hydroxycinnamic acid, ferulic acid, 5-chloro-2-mercaptobenzothionazole) for MALDI-TOF MS analysis nor by testing different culture conditions (cultivation length, culture media).


Folia Microbiologica | 2017

Methods of Candida dubliniensis identification and its occurrence in human clinical material

Martina Mahelová; Filip Růžička


Klinická mikrobiologie a infekc̆ní lékar̆ství | 2012

Yeast colonization of urinary catheters and the significance of biofilm formation

Filip Růžička; Holá; Martina Mahelová; Procházková A


Archive | 2016

XXV. Tomáškovy dny mladých mikrobiologů

Filip Růžička; Martina Mahelová; Tereza Peroutková; Petra Šišková


Archive | 2015

Production of virulence factors by Candida isolates causing bloodstream infections

Martina Mahelová; Filip Růžička


Archive | 2015

Molekulární analýza izolátů Clostridium difficile ve FN u Sv.Anny v Brně

Renata Tejkalová; M Krůtová; Leona Mejzlíková; Martina Mahelová; Ivana Matulová; Filip Růžička; O Nyc


Archive | 2015

Production of biofilm by Candida spp. isolated from bloodstream infections

Martina Mahelová; Filip Růžička


Archive | 2015

Biofilm detection by Raman spectrometry

Katarína Rebrošová; Ota Samek; Silvie Bernatová; Jan Ježek; Martin Šiler; Pavel Zemánek; Filip Růžička; Veronika Holá; Martina Mahelová

Collaboration


Dive into the Martina Mahelová's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jan Ježek

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin Šiler

Academy of Sciences of the Czech Republic

View shared research outputs
Researchain Logo
Decentralizing Knowledge